Form 4: Verizon Executive Kyle Malady Reports Stock Transactions
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, reports the sale of Verizon common stock and acquisition of phantom stock units.
Summary
- On May 8, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., reported selling 9,701 shares of common stock at $43.81 per share.
- He also sold 299 shares at $43.815 per share.
- Following these transactions, Malady directly owns 307 shares of common stock.
- Additionally, he indirectly owns 18,693 shares through a 401(k) and 381,461.872 phantom stock units through a deferred compensation plan.
- He acquired 139.108 phantom stock units at a price of $12.44 per unit.
- These phantom stock units are the economic equivalent of common stock shares and are settled in cash upon certain events.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency into executive stock ownership.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 05/08/2025 | Date of stock sale and phantom stock acquisition. |
| 05/09/2025 | Date of signature by Attorney-in-fact. |
Keywords
Verizon, Stock Sale, Phantom Stock, Form 4, Executive Compensation, VZ, Kyle Malady, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.